{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:12:04Z","timestamp":1791306724641,"version":"4.3.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:00:00Z","timestamp":1309219200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001216","type":"journal-article","created":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T20:39:15Z","timestamp":1309293555000},"page":"e1216","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":61,"title":["Parasitic Loads in Tissues of Mice Infected with Trypanosoma cruzi and Treated with AmBisome"],"prefix":"10.1371","volume":"5","author":[{"given":"Sabrina","family":"Cencig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Coltel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Truyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"key":"ref1","first-page":"1","article-title":"Trypanosomiase am\u00e9ricaine ou maladie de Chagas.","author":"Y Carlier","year":"2002","journal-title":"Encyclop\u00e9die M\u00e9dico-Chirurgicale"},{"key":"ref2","first-page":"539","article-title":"Maternal-Fetal Transmission of Trypanosoma cruzi.","author":"Y Carlier","year":"2010"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease.","volume":"375","author":"A Rassi Jr","year":"2010","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/nature09221","article-title":"Chagas disease : a new worldwide challenge.","volume":"465","author":"JR Coura","year":"2010","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1086\/605091","article-title":"An estimate of the burden of Chagas disease in the United States.","volume":"49","author":"C Bern","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10995-007-0246-8","article-title":"Mother-to-child transmission of Chagas' disease in North America: why don't we do more?","volume":"12","author":"P Buekens","year":"2008","journal-title":"Matern Child Health J"},{"key":"ref7","article-title":"Chagas disease in Spain, the United States and other non-endemic countries.","author":"J Gascon","year":"2009","journal-title":"Acta Trop"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3201\/eid1404.070489","article-title":"Chagas disease, France.","volume":"14","author":"FX Lescure","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis.","volume":"21","author":"SL Croft","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/01.qco.0000247592.21295.a5","article-title":"Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina.","volume":"19","author":"S Sosa-Estani","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.","volume":"144","author":"R Viotti","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14787210.7.2.157","article-title":"Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.","volume":"7","author":"R Viotti","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1371\/journal.pntd.0000484","article-title":"New, improved treatments for Chagas disease: from the R&D pipeline to the patients.","volume":"3","author":"I Ribeiro","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.","volume":"115","author":"JA Urbina","year":"2010","journal-title":"Acta Trop"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00003088-199223040-00004","article-title":"Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics.","volume":"23","author":"R Janknegt","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/j.1326-5377.2007.tb01313.x","article-title":"Antifungal agents.","volume":"187","author":"SC Chen","year":"2007","journal-title":"Med J Aust"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","article-title":"Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.","volume":"69","author":"MD Moen","year":"2009","journal-title":"Drugs"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1348-0421.2006.tb03832.x","article-title":"Evaluation of antifungal pharmacodynamic characteristics of AmBisome against Candida albicans.","volume":"50","author":"K Takemoto","year":"2006","journal-title":"Microbiol Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-6851(02)00280-3","article-title":"Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa.","volume":"126","author":"CW Roberts","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis.","volume":"43","author":"C Bern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"F Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.02297-05","article-title":"Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis.","volume":"44","author":"I Cruz","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref23","first-page":"1102","article-title":"[First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].","volume":"12","author":"P Minodier","year":"2005","journal-title":"Arch Pediatr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1586\/eri.10.78","article-title":"Current diagnosis and treatment of visceral leishmaniasis.","volume":"8","author":"S Mondal","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0005-2736(74)90316-2","article-title":"Isolation of the plasma membrane of a trypanosomatid flagellate: general characterisation and lipid composition.","volume":"339","author":"RC Hunt","year":"1974","journal-title":"Biochim Biophys Acta"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for Chagas disease.","volume":"104","author":"JA Urbina","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref27","first-page":"41","article-title":"[The \u201cin vitro\u201d action of amphotericin B on Trypanosoma cruzi.].","volume":"36","author":"H Abitbol","year":"1960","journal-title":"Rev Soc Argent Biol"},{"key":"ref28","first-page":"145","article-title":"Screening of drugs for rapid activity against Trypanosoma cruzi trypomastigotes in vitro.","volume":"39","author":"SL Croft","year":"1988","journal-title":"Trop Med Parasitol"},{"key":"ref29","first-page":"1219","article-title":"Differential effect of amphotericin B on the three evolutive stages of Trypanosoma cruzi and on the host cell-parasite interaction.","volume":"26","author":"SL de Castro","year":"1993","journal-title":"Braz J Med Biol Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0009-2797(89)90092-6","article-title":"Amphotericin B-induced damage of Trypanosoma cruzi epimastigotes.","volume":"71","author":"RM Haido","year":"1989","journal-title":"Chem Biol Interact"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1550-7408.1992.tb04859.x","article-title":"Amphotericin B-induced carbohydrate changes on the Trypanosoma cruzi surface membrane.","volume":"39","author":"RM Haido","year":"1992","journal-title":"J Protozool"},{"key":"ref32","first-page":"144","article-title":"The effect of amphotericin B on Trypanosoma cruzi in vitro and in vivo.","volume":"77","author":"AE Horvath","year":"1974","journal-title":"J Trop Med Hyg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijantimicag.2006.02.025","article-title":"Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi.","volume":"28","author":"M Rolon","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.1999.61.193","article-title":"In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections.","volume":"61","author":"V Yardley","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1590\/S0074-02762009000700021","article-title":"A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI.","volume":"104","author":"B Zingales","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/infdis\/96.3.199","article-title":"Connective tissue reactions in normal and immunized mice to a reticulotropic strain of T. cruzi.","volume":"96","author":"WH Talliaferro","year":"1955","journal-title":"J Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm1744","article-title":"Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.","volume":"14","author":"JM Bustamante","year":"2008","journal-title":"Nat Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20071393","article-title":"Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis.","volume":"205","author":"X Ye","year":"2008","journal-title":"J Exp Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-6851(03)00093-8","article-title":"Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR.","volume":"129","author":"KL Cummings","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.4269\/ajtmh.2006.75.1082","article-title":"Amniotic fluid is not useful for diagnosis of congenital Trypanosoma cruzi infection.","volume":"75","author":"M Virreira","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4269\/ajtmh.2007.77.102","article-title":"Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns.","volume":"77","author":"M Virreira","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4269\/ajtmh.1987.37.534","article-title":"Interactions between chronic murine Trypanosoma cruzi infection and pregnancy: fetal growth retardation.","volume":"37","author":"Y Carlier","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1128\/IAI.55.10.2496-2501.1987","article-title":"Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi.","volume":"55","author":"Y Carlier","year":"1987","journal-title":"Infect Immun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"24085","DOI":"10.1074\/jbc.M412802200","article-title":"The adipocyte as an important target cell for Trypanosoma cruzi infection.","volume":"280","author":"TP Combs","year":"2005","journal-title":"J Biol Chem"},{"key":"ref45","first-page":"721","article-title":"Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.","volume":"63","author":"SG Andrade","year":"1985","journal-title":"Bull World Health Organ"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1371\/journal.pntd.0000578","article-title":"The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice.","volume":"4","author":"LR Sardinha","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/IAI.35.1.46-51.1982","article-title":"Induction of the acute-phase protein serum amyloid P in experimental Chagas' disease.","volume":"35","author":"J Scharfstein","year":"1982","journal-title":"Infect Immun"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/9544","article-title":"Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity.","volume":"5","author":"MC Bickerstaff","year":"1999","journal-title":"Nat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI117474","article-title":"The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.","volume":"94","author":"WL Hutchinson","year":"1994","journal-title":"J Clin Invest"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002329900086","article-title":"Amphotericin B kills unicellular leishmanias by forming aqueous pores permeable to small cations and anions.","volume":"152","author":"H Ramos","year":"1996","journal-title":"J Membr Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/AAC.34.3.381","article-title":"Amphotericin B: delivery systems.","volume":"34","author":"J Brajtburg","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/clinids\/22.Supplement_2.S133","article-title":"Lipid formulations of amphotericin B: recent progress and future directions.","volume":"22","author":"JW Hiemenz","year":"1996","journal-title":"Clin Infect Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.siny.2005.08.007","article-title":"Physiology of the fetal circulation.","volume":"10","author":"T Kiserud","year":"2005","journal-title":"Semin Fetal Neonatal Med"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T23:09:44Z","timestamp":1592694584000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001216"}},"subtitle":[],"editor":[{"given":"Ana","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001216","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]}}}